Rouan Sarah Kathryn — SEC Form 4 filings
SEC reporting owner CIK 1761366. 7 Form 4 filings on record with FilingPulse; latest filed 2026-01-05.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-01-19 to 2026-01-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 2,480 shares, $59,886 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 3 legs across 3 filings — 66,000 shares, $2,282,540 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: sale of 11,000 shares @ $80.89 ($889,790) in Viking Therapeutics, Inc., filed 2024-10-25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Viking Therapeutics, Inc. (VKTX) | Director | 7 | 2 legs · 2,480 sh · $59,886 | 3 legs · 66,000 sh · $2,282,540 | 9 |
Form 4 filings — Rouan Sarah Kathryn
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-05 | 4 | Viking Therapeutics, Inc. (VKTX) | Grant/award (A): 3,150 @ $0 · Grant/award (A): 20,400 (derivative) @ $0 | EDGAR |
| 2025-04-08 | 4/A | Viking Therapeutics, Inc. (VKTX) | Purchase (P): 1,240 @ $24.15 | EDGAR |
| 2025-04-02 | 4 | Viking Therapeutics, Inc. (VKTX) | Purchase (P): 1,240 @ $24.15 | EDGAR |
| 2025-01-06 | 4 | Viking Therapeutics, Inc. (VKTX) | Grant/award (A): 18,800 (derivative) @ $0 | EDGAR |
| 2024-10-25 | 4 | Viking Therapeutics, Inc. (VKTX) | Option exercise (M): 11,000 @ $4.88 · Sale (S): 11,000 @ $80.89 · Option exercise (M): 11,000 (derivative) @ $0 | EDGAR |
| 2024-02-08 | 4 | Viking Therapeutics, Inc. (VKTX) | Option exercise (M): 25,000 @ $8.32 · Sale (S): 25,000 @ $28.05 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2024-01-19 | 4 | Viking Therapeutics, Inc. (VKTX) | Option exercise (M): 30,000 @ $8.32 · Sale (S): 30,000 @ $23.05 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1761366 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →